Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-25-011708
Filing Date
2025-04-02
Accepted
2025-04-02 06:02:08
Documents
6
Effectiveness Date
2025-04-02

Document Format Files

Seq Description Document Type Size
1 S-8 ef20046763_s8.htm S-8 55818
2 EXHIBIT 5.1 ef20046763_ex5-1.htm EX-5.1 10199
3 EXHIBIT 23.1 ef20046763_ex23-1.htm EX-23.1 3014
4 EXHIBIT 99.3 ef20046763_ex99-3.htm EX-99.3 145033
5 EXHIBIT 107 ef20046763_ex107.htm EX-FILING FEES 40632
6 image00001.jpg GRAPHIC 2777
  Complete submission text file 0001140361-25-011708.txt   260024
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286325 | Film No.: 25801874
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)